A Study to Examine the Effectiveness of Aspirin and/or Vitamin D3 to Prevent Prostate Cancer Progression

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions
Prostate Cancer
Interventions
DRUG

High dose Aspirin & Vitamin D

Aspirin 1 x 300mg tablet daily \& Vitamin D 4,000IU daily. (8 drops).

DRUG

High dose Aspirin, Vitamin D placebo

Aspirin 1 x 300mg tablet daily \& Vitamin D placebo (8 drops).

DRUG

Low dose Aspirin , Vitamin D

Aspirin 1 x 100mg tablet daily \& Vitamin D 4,000IU daily. (8 drops).

DRUG

Low dose Aspirin, Vitamin D placebo

Aspirin 1 x 100mg tablet daily \& Vitamin D placebo 8 drops daily.

DRUG

Aspirin Placebo, Vitamin D

Aspirin 1 x 300mg placebo tablet daily \& Vitamin D 4,000IU daily. (8 drops).

DRUG

Aspirin placebo, Vitamin D placebo

Aspirin 1 x 100mg placebo tablet daily \& Vitamin D 4,000IU daily. (8 drops).

Trial Locations (7)

DA2 8DA

Darent Valley Hospital, Dartford

CF14 4XW

University Hospital of Wales, London

CV2 2DX

University Hospital UHCW NHS Trust, London

EC1A 7BE

St Bartholomews Hospital London, Bart's and the London school of Medicine, London

NW1 2B

University College Hospital London, London

Unknown

Homerton Hospital, London

S016 6YD

Southampton General Hospital, Southampton

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Barts and the London School of Medicine and Dentistry

OTHER

collaborator

Cancer Research UK

OTHER

lead

Queen Mary University of London

OTHER